{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:31:19Z","timestamp":1789957879240,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Changes in the mesolimbic dopamine (DA) system are implicated in a range of neuropsychiatric conditions including addiction, depression and schizophrenia. Dysfunction of the neuroimmune system is often comorbid with such conditions and affects similar areas of the brain. The goal of this study was to use positron emission tomography with the dopamine D\n                    <jats:sub>2<\/jats:sub>\n                    antagonist tracer,\n                    <jats:sup>11<\/jats:sup>\n                    C-raclopride, to explore the effect of acute immune activation on striatal DA levels. DA transmission was modulated by an oral methylphenidate (MP) challenge in order to reliably elicit DA elevation. Elevation in DA concentration due to MP was estimated via change in\n                    <jats:sup>11<\/jats:sup>\n                    C-raclopride binding potential from the baseline scan. Prior to the post-MP scan, subjects were pre-treated with either the immune activator lipopolysaccharide (LPS) or placebo (PBO) in a cross-over design. Immune activation was confirmed by measuring tumor necrosis factor alpha (TNF\u03b1), interleukin (IL)-6 and IL-8 concentration in plasma. Eight healthy subjects were scanned four times each to determine the MP-induced DA elevation under both LPS and PBO pre-treatment conditions. MP-induced DA elevation in the striatum was significantly greater (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.01) after LPS pre-treatment compared to PBO pre-treatment. Seven of eight subjects responded similarly. This effect was observed in the caudate and putamen (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.02), but was not present in ventral striatum. DA elevation induced by MP was significantly greater when subjects were pre-treated with LPS compared to PBO. The amplification of stimulant-induced DA signaling in the presence of systemic inflammation may have important implications for our understanding of addiction and other diseases of DA dysfunction.\n                  <\/jats:p>","DOI":"10.1038\/tp.2017.18","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T11:43:18Z","timestamp":1490701398000},"page":"e1076-e1076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Systemic inflammation enhances stimulant-induced striatal dopamine elevation"],"prefix":"10.1038","volume":"7","author":[{"given":"J R","family":"Petrulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Kalish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N B","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hannestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E D","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"BFtp201718_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cellimm.2015.04.006","volume":"296","author":"M Kostic","year":"2015","unstructured":"Kostic M, Stojanovic I, Marjanovic G, Zivkovic N, Cvetanovic A . Deleterious versus protective autoimmunity in multiple sclerosis. Cell Immunol 2015; 296: 122\u2013132.","journal-title":"Cell Immunol"},{"key":"BFtp201718_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol 2015; 14: 388\u2013405.","journal-title":"Lancet Neurol"},{"key":"BFtp201718_CR3","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","volume":"46","author":"A Vezzani","year":"2005","unstructured":"Vezzani A, Granata T . Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005; 46: 1724\u20131743.","journal-title":"Epilepsia"},{"key":"BFtp201718_CR4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.bbi.2011.03.003","volume":"25","author":"FT Crews","year":"2011","unstructured":"Crews FT, Zou J, Qin L . Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav Immun 2011; 25: S4\u2013S12.","journal-title":"Brain Behav Immun"},{"key":"BFtp201718_CR5","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.bbi.2010.12.013","volume":"25","author":"KW Kelley","year":"2011","unstructured":"Kelley KW, Dantzer R . Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders. Brain Behav Immun 2011; 25: S13\u2013S20.","journal-title":"Brain Behav Immun"},{"key":"BFtp201718_CR6","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/nn.4113","volume":"18","author":"GE Hodes","year":"2015","unstructured":"Hodes GE, Kana V, Menard C, Merad M, Russo SJ . Neuroimmune mechanisms of depression. Nat Neurosci 2015; 18: 1386\u20131393.","journal-title":"Nat Neurosci"},{"key":"BFtp201718_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/PSY.0000000000000311","volume":"78","author":"ML Byrne","year":"2016","unstructured":"Byrne ML, Whittle S, Allen NB . The role of brain structure and function in the association between inflammation and depressive symptoms: a systematic review. Psychosom Med 2016; 78: 389\u2013400.","journal-title":"Psychosom Med"},{"key":"BFtp201718_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB . Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2015; 2: 258\u2013270.","journal-title":"Lancet Psychiatry"},{"key":"BFtp201718_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","volume":"42","author":"A Monji","year":"2013","unstructured":"Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry 2013; 42: 115\u2013121.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp201718_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrn3978","volume":"16","author":"ML Estes","year":"2015","unstructured":"Estes ML, McAllister AK . Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci 2015; 16: 469\u2013486.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201718_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.neuroimage.2009.04.040","volume":"47","author":"NI Eisenberger","year":"2009","unstructured":"Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR . An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 2009; 47: 881\u2013890.","journal-title":"Neuroimage"},{"key":"BFtp201718_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","volume":"68","author":"NI Eisenberger","year":"2010","unstructured":"Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR . Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 2010; 68: 748\u2013754.","journal-title":"Biol Psychiatry"},{"key":"BFtp201718_CR13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/npp.2014.222","volume":"40","author":"NA Harrison","year":"2015","unstructured":"Harrison NA, Cercignani M, Voon V, Critchley HD . Effects of inflammation on hippocampus and substantia nigra responses to novelty in healthy human participants. Neuropsychopharmacology 2015; 40: 831\u2013838.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201718_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2967\/jnumed.111.097014","volume":"53","author":"J Hannestad","year":"2012","unstructured":"Hannestad J, Subramanyam K, Dellagioia N, Planeta-Wilson B, Weinzimmer D, Pittman B et al. Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans. J Nucl Med 2012; 53: 601\u2013607.","journal-title":"J Nucl Med"},{"key":"BFtp201718_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbi.2012.10.008","volume":"31","author":"N DellaGioia","year":"2013","unstructured":"DellaGioia N, Devine L, Pittman B, Hannestad J . Bupropion pre-treatment of endotoxin-induced depressive symptoms. Brain Behav Immun 2013; 31: 197\u2013204.","journal-title":"Brain Behav Immun"},{"key":"BFtp201718_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbi.2010.10.013","volume":"25","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Ortiz N, Pittman B, Bhagwagar Z . Citalopram reduces endotoxin-induced fatigue. Brain Behav Immun 2011; 25: 256\u2013259.","journal-title":"Brain Behav Immun"},{"key":"BFtp201718_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/jamapsychiatry.2015.1977","volume":"73","author":"M Jokela","year":"2016","unstructured":"Jokela M, Virtanen M, Batty GD, Kivimaki M . Inflammation and specific symptoms of depression. JAMA Psychiatry 2016; 73: 87\u201388.","journal-title":"JAMA Psychiatry"},{"key":"BFtp201718_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neubiorev.2016.02.017","volume":"64","author":"W Swardfager","year":"2016","unstructured":"Swardfager W, Rosenblat JD, Benlamri M, McIntyre RS . Mapping inflammation onto mood: Inflammatory mediators of anhedonia. Neurosci Biobehav Rev 2016; 64: 148\u2013166.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtp201718_CR19","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/npp.2015.17","volume":"40","author":"M Moieni","year":"2015","unstructured":"Moieni M, Irwin MR, Jevtic I, Olmstead R, Breen EC, Eisenberger NI . Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology 2015; 40: 1709\u20131716.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201718_CR20","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/mp.2015.168","volume":"21","author":"JC Felger","year":"2016","unstructured":"Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry 2016; 21: 1358\u20131365.","journal-title":"Mol Psychiatry"},{"key":"BFtp201718_CR21","doi-asserted-by":"publisher","first-page":"12468","DOI":"10.1073\/pnas.1511003112","volume":"112","author":"CM Sandiego","year":"2015","unstructured":"Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF et al. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci USA 2015; 112: 12468\u201312473.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp201718_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.bp.114.154393","volume":"207","author":"NA Crossley","year":"2015","unstructured":"Crossley NA, Scott J, Ellison-Wright I, Mechelli A . Neuroimaging distinction between neurological and psychiatric disorders. Br J Psychiatry 2015; 207: 429\u2013434.","journal-title":"Br J Psychiatry"},{"key":"BFtp201718_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamapsychiatry.2014.2206","volume":"72","author":"M Goodkind","year":"2015","unstructured":"Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 2015; 72: 305\u2013315.","journal-title":"JAMA Psychiatry"},{"key":"BFtp201718_CR24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0022-3565(25)11171-3","volume":"261","author":"AJ Dunn","year":"1992","unstructured":"Dunn AJ . Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J Pharmacol Exp Ther 1992; 261: 964\u2013969.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp201718_CR25","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/npp.2013.115","volume":"38","author":"JC Felger","year":"2013","unstructured":"Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR et al. Chronic interferon-alpha decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology 2013; 38: 2179\u20132187.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201718_CR26","doi-asserted-by":"crossref","unstructured":"Felger JC, Hernandez CR, Miller AH . Levodopa reverses cytokine-induced reductions in striatal dopamine release. Int J Neuropsychopharmacol 2015; 18: pyu084.","DOI":"10.1093\/ijnp\/pyu084"},{"key":"BFtp201718_CR27","first-page":"1285","volume":"40","author":"GJ Wang","year":"1999","unstructured":"Wang GJ, Volkow ND, Fowler JS, Logan J, Pappas NR, Wong CT et al. Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate. J Nucl Med 1999; 40: 1285\u20131291.","journal-title":"J Nucl Med"},{"key":"BFtp201718_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/syn.890160402","volume":"16","author":"ND Volkow","year":"1994","unstructured":"Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R et al. Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 1994; 16: 255\u2013262.","journal-title":"Synapse"},{"key":"BFtp201718_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/syn.10038","volume":"43","author":"ND Volkow","year":"2002","unstructured":"Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L et al. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 2002; 43: 181\u2013187.","journal-title":"Synapse"},{"key":"BFtp201718_CR30","doi-asserted-by":"publisher","first-page":"RC121","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001","volume":"21","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001; 21: RC121.","journal-title":"J Neurosci"},{"key":"BFtp201718_CR31","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/00006231-200312000-00002","volume":"24","author":"J Hirvonen","year":"2003","unstructured":"Hirvonen J, Aalto S, Lumme V, Nagren K, Kajander J, Vilkman H et al. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride. Nucl Med Commun 2003; 24: 1207\u20131214.","journal-title":"Nucl Med Commun"},{"key":"BFtp201718_CR32","doi-asserted-by":"publisher","first-page":"16851","DOI":"10.1523\/JNEUROSCI.3661-14.2014","volume":"34","author":"KP Cosgrove","year":"2014","unstructured":"Cosgrove KP, Wang S, Kim SJ, McGovern E, Nabulsi N, Gao H et al. Sex differences in the brain's dopamine signature of cigarette smoking. J Neurosci 2014; 34: 16851\u201316855.","journal-title":"J Neurosci"},{"key":"BFtp201718_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.biopsych.2011.08.024","volume":"71","author":"D Martinez","year":"2012","unstructured":"Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D, Grassetti A et al. Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry 2012; 71: 192\u2013198.","journal-title":"Biol Psychiatry"},{"key":"BFtp201718_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.euroneuro.2015.12.007","volume":"26","author":"K Ledermann","year":"2016","unstructured":"Ledermann K, Jenewein J, Sprott H, Hasler G, Schnyder U, Warnock G et al. Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression - A [(11)C] raclopride PET-study. Eur Neuropsychopharmacol 2016; 26: 320\u2013330.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp201718_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.schres.2015.02.020","volume":"164","author":"S Nakajima","year":"2015","unstructured":"Nakajima S, Caravaggio F, Mamo DC, Mulsant BH, Chung JK, Plitman E et al. Dopamine D(2)\/(3) receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [(1)(1)C]-raclopride PET study. Schizophr Res 2015; 164: 263\u2013267.","journal-title":"Schizophr Res"},{"key":"BFtp201718_CR36","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/mp.2010.97","volume":"16","author":"ND Volkow","year":"2011","unstructured":"Volkow ND, Wang GJ, Newcorn JH, Kollins SH, Wigal TL, Telang F et al. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry 2011; 16: 1147\u20131154.","journal-title":"Mol Psychiatry"},{"key":"BFtp201718_CR37","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/(SICI)1099-1344(199912)42:12<1183::AID-JLCR274>3.0.CO;2-Z","volume":"42","author":"O Langer","year":"1999","unstructured":"Langer O, Nagren K, Dolle F, Lundkvist C, Sandell J, Swahn CG et al. Precursor synthesis and radiolabelling of the dopamine D-2 receptor ligand [C-11]raclopride from [C-11]methyl triflate. J Labelled Compd Rad 1999; 42: 1183\u20131193.","journal-title":"J Labelled Compd Rad"},{"key":"BFtp201718_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2967\/jnumed.108.058628","volume":"50","author":"FH van Velden","year":"2009","unstructured":"van Velden FH, Kloet RW, van Berckel BN, Buijs FL, Luurtsema G, Lammertsma AA et al. HRRT versus HR+ human brain PET studies: an interscanner test-retest study. J Nucl Med 2009; 50: 693\u2013702.","journal-title":"J Nucl Med"},{"key":"BFtp201718_CR39","volume-title":"Manual for the Profile of Mood States","author":"DM McNair","year":"1971","unstructured":"McNair DM, Lorr M, Droppleman LF . Manual for the Profile of Mood States. Educational and Industrial Testing Services: San Diego, CA, 1971."},{"key":"BFtp201718_CR40","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM . FSL. Neuroimage 2012; 62: 782\u2013790.","journal-title":"Neuroimage"},{"key":"BFtp201718_CR41","first-page":"209","volume":"2006","author":"X Papademetris","year":"2006","unstructured":"Papademetris X, Jackowski MP, Rajeevan N, DiStasio M, Okuda H, Constable RT et al. BioImage suite: an integrated medical image analysis suite: an update. Insight J 2006; 2006: 209.","journal-title":"Insight J"},{"key":"BFtp201718_CR42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1109\/42.712135","volume":"17","author":"DL Collins","year":"1998","unstructured":"Collins DL, Zijdenbos AP, Kollokian V, Sled JG, Kabani NJ, Holmes CJ et al. Design and construction of a realistic digital brain phantom. IEEE Trans Med Imaging 1998; 17: 463\u2013468.","journal-title":"IEEE Trans Med Imaging"},{"key":"BFtp201718_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273\u2013289.","journal-title":"Neuroimage"},{"key":"BFtp201718_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 2003; 23: 285\u2013300.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3 Pt 1","key":"BFtp201718_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP . Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4 (3 Pt 1): 153\u2013158.","journal-title":"Neuroimage"},{"key":"BFtp201718_CR46","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1152\/japplphysiol.01429.2005","volume":"100","author":"DL Chen","year":"2006","unstructured":"Chen DL, Rosenbluth DB, Mintun MA, Schuster DP . FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin. J Appl Physiol 2006; 100: 1602\u20131609.","journal-title":"J Appl Physiol"},{"key":"BFtp201718_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","volume":"58","author":"A Reichenberg","year":"2001","unstructured":"Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001; 58: 445\u2013452.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp201718_CR48","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.biopsych.2010.06.017","volume":"68","author":"J Hannestad","year":"2010","unstructured":"Hannestad J, Gallezot JD, Planeta-Wilson B, Lin SF, Williams WA, van Dyck CH et al. Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biol Psychiatry 2010; 68: 854\u2013860.","journal-title":"Biol Psychiatry"},{"key":"BFtp201718_CR49","doi-asserted-by":"publisher","first-page":"e740","DOI":"10.1038\/tp.2016.6","volume":"6","author":"L Booij","year":"2016","unstructured":"Booij L, Welfeld K, Leyton M, Dagher A, Boileau I, Sibon I et al. Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers. Transl Psychiatry 2016; 6: e740.","journal-title":"Transl Psychiatry"},{"key":"BFtp201718_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0006-8993(97)01319-X","volume":"783","author":"MS Reid","year":"1998","unstructured":"Reid MS, Ho LB, Tolliver BK, Wolkowitz OM, Berger SP . Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatment. Brain Res 1998; 783: 133\u2013142.","journal-title":"Brain Res"},{"key":"BFtp201718_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bbr.2015.03.054","volume":"287","author":"LS Tortorelli","year":"2015","unstructured":"Tortorelli LS, Engelke DS, Lunardi P, Mello EST, Santos-Junior JG, Goncalves CA . Cocaine counteracts LPS-induced hypolocomotion and triggers locomotor sensitization expression. Behav Brain Res 2015; 287: 226\u2013229.","journal-title":"Behav Brain Res"},{"key":"BFtp201718_CR52","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2011.2094","volume":"69","author":"L Capuron","year":"2012","unstructured":"Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ et al. Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry 2012; 69: 1044\u20131053.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp201718_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00213-013-3141-6","volume":"230","author":"A Bari","year":"2013","unstructured":"Bari A, Robbins TW . Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD. Psychopharmacology 2013; 230: 89\u2013111.","journal-title":"Psychopharmacology"},{"key":"BFtp201718_CR54","doi-asserted-by":"publisher","first-page":"e1143","DOI":"10.1371\/journal.pone.0001143","volume":"2","author":"LS Colzato","year":"2007","unstructured":"Colzato LS, van den Wildenberg WP, Hommel B . Impaired inhibitory control in recreational cocaine users. PLoS ONE 2007; 2: e1143.","journal-title":"PLoS ONE"},{"key":"BFtp201718_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.drugalcdep.2005.02.002","volume":"79","author":"JR Monterosso","year":"2005","unstructured":"Monterosso JR, Aron AR, Cordova X, Xu J, London ED . Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005; 79: 273\u2013277.","journal-title":"Drug Alcohol Depend"},{"key":"BFtp201718_CR56","doi-asserted-by":"publisher","first-page":"5990","DOI":"10.1523\/JNEUROSCI.4850-14.2015","volume":"35","author":"CL Robertson","year":"2015","unstructured":"Robertson CL, Ishibashi K, Mandelkern MA, Brown AK, Ghahremani DG, Sabb F et al. Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects. J Neurosci 2015; 35: 5990\u20135997.","journal-title":"J Neurosci"},{"key":"BFtp201718_CR57","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1176\/appi.ajp.158.12.2015","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158: 2015\u20132021.","journal-title":"Am J Psychiatry"},{"key":"BFtp201718_CR58","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.1523\/JNEUROSCI.4284-11.2012","volume":"32","author":"DG Ghahremani","year":"2012","unstructured":"Ghahremani DG, Lee B, Robertson CL, Tabibnia G, Morgan AT, De Shetler N et al. Striatal dopamine D(2)\/D(3) receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci 2012; 32: 7316\u20137324.","journal-title":"J Neurosci"},{"key":"BFtp201718_CR59","doi-asserted-by":"publisher","first-page":"14734","DOI":"10.1523\/JNEUROSCI.3765-09.2009","volume":"29","author":"B Lee","year":"2009","unstructured":"Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR et al. Striatal dopamine d2\/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 2009; 29: 14734\u201314740.","journal-title":"J Neurosci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp201718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201718","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/tp.2017.18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/tp201718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:56:14Z","timestamp":1750172174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp201718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"alternative-id":["BFtp201718"],"URL":"https:\/\/doi.org\/10.1038\/tp.2017.18","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]},"assertion":[{"value":"28 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}